FINRA BrokerCheck CRD Expungement Attorney
Did you lose money investing in Avadel Pharmaceuticals (AVDLQ)? Galvin Legal, PLLC is launching an investigation on behalf of investors who suffered losses investing in Avadel Pharmaceuticals (AVDLQ) at the recommendation of their financial advisor. Read More
Did you lose money investing in Insys Therapeutics? Galvin Legal, PLLC is launching an investigation on behalf of investors who suffered losses investing in Insys Therapeutics at the recommendation of their financial advisor. If you suffered losses Read More
Did you lose money investing in Aegerion Pharmaceuticals (AEGR)? Galvin Legal, PLLC is launching an investigation on behalf of investors who suffered losses investing in Aegerion Pharmaceuticals (AEGR) at the recommendation of their financial Read More
Did you lose money investing in Canopy Growth Corporation (CGC)? Galvin Legal, PLLC is launching an investigation on behalf of investors who suffered losses investing in Canopy Growth Corporation (CGC) at the recommendation of their financial Read More
Galvin Legal challenged FINRA Overreach and Forced a Rule Change on Hearing Record Access. At Galvin Legal, PLLC, we are committed to ensuring fairness for registered representatives within the FINRA dispute resolution system. A critical aspect of this commitment involves holding FINRA accountable to its own rules and the law. A notable example of thisRead More
Galvin Legal Advances Significant Arbitration Claim Against Taglich Brothers, Michael Taglich, Robert Taglich, and Richard Oh; Panel Denies Dismissal of Bioventrix Claims With Prejudice Galvin Legal is actively pursuing a significant FINRA arbitration claim filed on behalf of investors against Taglich Brothers, Inc., and its principals, Michael Nicolas Taglich, Robert Francis Taglich, and Richard C.Read More
